- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01115361
Postpartum Family Planning Service Through Enhanced Family Planning in Immunization Services (PPFP-IZ)
Improving Access to and Uptake of Postpartum Family Planning Service Through Enhanced Family Planning in Immunization Services
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Study Goal:
To determine the effectiveness of an intervention, which is designed to increase contraceptive prevalence among postpartum women attending vaccination services who desire to either space or limit their pregnancies, thus reducing unmet contraceptive need in this population.
The Intervention:
A. Brief, concise messages conveyed to women during group education sessions regarding pregnancy risk, benefits of FP, and family planning options during the postpartum period.
B.IEC materials such as posters and brochures that deliver messages about the benefits of spacing pregnancies by at least 2 years, LAM, return to fecundity and pregnancy risk during the postpartum period and contraceptive options for postpartum women.
C.Use of a screening tool (Appendix A) to assess pregnancy risk for postpartum women coupled with a brief counseling message depending upon risk classification which includes referral to FP services for those currently or soon-to-be at-risk of pregnancy.
D.Convenient offer of FP services to women attending vaccination services for their infants either concurrently with vaccination services, or at the same facility and on the same day, but at a different time from vaccination services.
Study Design:
Experimental, two-group (intervention/control) pretest (pre-intervention) /posttest (post-intervention) design 12 month intervention period. A mid-course collection of process data will also be conducted at 6 months to assess the degree to which the intervention is being implemented as intended and to provide an opportunity for corrective action if needed.
Participants: Women attending vaccination services for their infants, and vaccination and FP providers
Type d'étude
Inscription (Anticipé)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Kigali, Rwanda
- Rwanda health care facilities
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
Clients:
- adult women, aged 21 years and older, or married women ages 18 to 20 who have achieved legal majority status by emancipation due to marriage,
- bring their infants between the ages 6-12 months to immunization services at study sites
Providers:
- all health care providers who currently provide immunization services to infants and/or family planning services within the selected facilities.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Recherche sur les services de santé
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: PPFP in child immunization
Women attending immunization services for their infant will receive educational brochures, group education and individual counseling on the benefits of the health timing and spacing of births,, pregnancy risk and return to fertility during the extended postpartum period (12 months), and referral to family planning services for those who are interested.
|
A.Group education sessions regarding pregnancy risk, benefits of FP, and family planning options during the postpartum period. B. IEC materials that deliver messages about the benefits of spacing pregnancies by at least 2 years, LAM, return to fecundity and pregnancy risk during the postpartum period and contraceptive options for postpartum women. C. Use of a screening tool to assess pregnancy risk for postpartum women coupled with a brief counseling message and referral to FP services. D.Convenient offer of FP services to women attending vaccination services for their infants. |
Aucune intervention: Control - Standard of care
The control arm will receive standard of care infant immunization services.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Use of a modern contraceptive method among postpartum women
Délai: 1 year
|
The outcome variable is a dichotomous variable - use of modern FP method: yes/no
|
1 year
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Lisa S Dulli, PhD, MHS, FHI 360
- Directeur d'études: Steve Sortijas, MPH, FHI 360
- Chercheur principal: Fidèle Ngabo, MD, MPH, Ministry of Health, Rwanda
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- 890028
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur La contraception
-
Johnson & Johnson Pharmaceutical Research & Development...ComplétéContraception féminine | La contraception
-
Johnson & Johnson Pharmaceutical Research & Development...Complété
-
Teva Branded Pharmaceutical Products R&D, Inc.ComplétéContraception féminine | La contraceptionÉtats-Unis, Israël
-
Johnson & Johnson Pharmaceutical Research & Development...Complété
-
Johnson & Johnson Pharmaceutical Research & Development...ComplétéContraception féminine | La contraception
-
Johnson & Johnson Pharmaceutical Research & Development...ComplétéContraception féminine | La contraception
-
Janssen Pharmaceutica N.V., BelgiumComplété
-
Children's Mercy Hospital Kansas CityUniversity of Kansas Medical Center; Swope Health Services, Kansas City MissouriComplétéLa contraception | Utilisation de la contraceptionÉtats-Unis
-
Population CouncilBill and Melinda Gates FoundationRecrutementLa contraception | Utilisation de la contraceptionPakistan
-
Montefiore Medical CenterSociety of Family PlanningComplétéLa contraception | Allaitement maternel | Contraception post-partumÉtats-Unis
Essais cliniques sur Family planning for postpartum women
-
Maureen LyonNational Institute of Nursing Research (NINR); St. Jude Children's Research... et autres collaborateursComplété